A kind of high-efficiency anti-tumor targeted drug carrier and preparation method thereof

An anti-tumor drug and anti-tumor technology, applied in the direction of anti-tumor drugs, drug combinations, pharmaceutical formulations, etc., can solve the problems of wide molecular weight distribution, single function, uncontrollable molecular weight, etc., and achieve excellent performance, high targeting, good The effect of biocompatibility

Inactive Publication Date: 2017-02-08
INST OF CHEM CHINESE ACAD OF SCI
View PDF5 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the PHPMA carrier also has obvious shortcomings: it has a single function and does not have the function of preventing non-specific adsorption of proteins, resulting in the adsorption and accumulation of drugs in non-focused parts during blood circulation, resulting in insufficient circulation time of drug carriers in the body, affecting The therapeutic effect of the drug; in addition, because the preparation of the current PHPMA carrier generally adopts ordinary free radical polymerization, the molecular weight is uncontrollable and the molecular weight distribution is very wide, which seriously affects the EPR effect of the carrier and the release of the drug from the carrier, thereby further affecting the treatment of the drug Effect

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of high-efficiency anti-tumor targeted drug carrier and preparation method thereof
  • A kind of high-efficiency anti-tumor targeted drug carrier and preparation method thereof
  • A kind of high-efficiency anti-tumor targeted drug carrier and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0049] Embodiment 1, preparation PEG 5k -b-P(HPMA 30k -co-MAGG 5k -co-BHMAGG 8k )

[0050] Dissolve 2.4g of single-terminal hydroxyl or amino PEG with a number average molecular weight of 5000 in 40mL of dry toluene, add 0.68g of CPAD and 0.041g of DMAP, add 0.74g of DCC after complete dissolution, and stir at room temperature for 96 hours. Suction filtration, pour the filtrate into excess diethyl ether, and then suction filtration, the resulting precipitate was dissolved in a small amount of toluene, and then precipitated with diethyl ether, and this was repeated three times. The precipitate was vacuum-dried at 40° C. for 24 hours, and the obtained product was a macromolecular chain transfer agent of PEG.

[0051] Take 52mg of macromolecular chain transfer agent, 312.5mg of HPMA, 52mg of MAGG, 83mg of BHMAGG, 1mg of 4,4'-azobis(4-cyanovaleric acid), and 5mL of DMSO in a Shrek tube, evacuate under refrigeration, and then recover Return to room temperature, fill with argon...

Embodiment 2

[0053] Embodiment 2, preparation PEG 5k -b-P(HPMA 30k -co-MAGG 5k (Folate)-co-BHMAGG 8k )

[0054] Folate-NH 2 Preparation: 4.41g of folic acid and 10-fold excess of ethylene glycol bis-2-aminoethyl ether were used as solvent in anhydrous DMSO, and reacted at 35°C for 48 hours under the catalysis of EDC and NHS equivalent to folic acid. After the reaction was completed, the reaction solution was poured into water for precipitation. The filtrate was collected and freeze-dried, and the product was purified by semi-preparative liquid chromatography (Shimadzu LC-6AD, Japan).

[0055] PEG 5k -b-P(HPMA 30k -co-MAGG 5k (Folate)-co-BHMAGG8k ) preparation: the PEG prepared in Example 1 5k -b-P(HPMA 30k -co-MAGG 5k -co-BHMAGG 8k ) and Folate-NH 2 With anhydrous DMSO as solvent, it is prepared under the catalysis of EDC and NHS.

[0056] The specific steps are: take 0.5g PEG 5k -b-P(HPMA 30k -co-MAGG 5k -co-BHMAGG 8k ) was dissolved in 20ml of anhydrous DMSO, 0.3g of ED...

Embodiment 3

[0057] Example 3, PEG 5k -b-P(HPMA 30k -co-MAGG 5k (Folate)-co-HMAGG 8k (Dox)) preparation

[0058] The PEG prepared in 100mg embodiment 2 5k -b-P(HPMA 30k -co-MAGG 5k (Folate)-co-BHMAGG 8k ) first remove the Boc protection in 15ml of pure trifluoroacetic acid, the reaction time is 30 minutes, after the reaction is completed, the trifluoroacetic acid is removed by rotary evaporation to obtain PEG 5k -b-P(HPMA 30k -co-MAGG 5k (Folate)-co-HMAGG 5.4k ). The product was dissolved in 20ml of anhydrous DMSO, 100mg of Dox and 0.2ml of glacial acetic acid were added, and reacted at 37°C for 48 hours. After the reaction was completed, the resulting reaction solution was purified with a gel chromatographic column, and the characterization results were as follows: figure 2 with image 3 shown.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a novel efficient anti-tumor targeting drug carrier and a preparation method thereof. The carrier is a diblock copolymer consisting of a chain segment A and a chain segment B, wherein the chain segment A is PEG, and the chain segment B is a random copolymer formed by the following three monomers: HPMA, MAGG and BHMAGG. By adoption of a reversible addition fragmentation chain transfer polymerization method, the copolymer with controllable copolymerization components and molecular weight, and narrow molecular weight distribution (with the molecular weight distribution PDI being less than 1.4) is obtained. By modification of side chain functional groups of the MAGG and the BHMAGG in the polymer, a water-soluble polymer drug carrying system with significant targeting and controlled drug release functions is obtained. The polymer drug carrying system can be used for efficient transportation of anti-tumor drugs, has advantages of high targeting property, good biocompatibility, adjustable drug carrying amount, and drug release with pH responsiveness, and is an anti-tumor targeting drug carrier with excellent performances.

Description

technical field [0001] The invention relates to a class of high-efficiency anti-tumor targeting drug carrier and a preparation method thereof. Background technique [0002] Tumor has always been a major disease that threatens human health. At present, there are three main methods for the treatment of tumors: surgery, chemotherapy and radiotherapy. However, various treatment methods still have problems such as low cure rate, high recurrence and high mortality. At present, some chemotherapeutic drugs are commonly used clinically to treat tumors, such as doxorubicin, epirubicin, daunorubicin, carboplatin, nitrogen mustard (Chlormethine) and paclitaxel ( Paclitaxel) and other drugs have shown remarkable curative effect in the treatment of tumors, but there are still many problems, mainly because the drugs themselves lack targeting, and it is difficult to effectively reach the lesion site. At the same time, while these drugs kill tumor cells, they also non-selectively kill norma...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): C08F293/00C08F220/58C08F222/38C08F2/38C08G65/48C08F8/32C08F8/28A61K47/59A61K45/00A61K31/704A61P35/00
Inventor 喻青松甘志华
Owner INST OF CHEM CHINESE ACAD OF SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap